DNALinux logo

DNALinux is a Live Linux for bioinformatic use. Just boot your computer and have several bioinformatic software. Download and use it free.

Welcome to the Frontpage
Protein Computational Tools -- Deadline this Friday PDF Print E-mail
Written by Virginia Gonzalez   
Thursday, 18 November 2010 16:38
Inaugural Protein Computational Tools Mathematical Data Modeling Solutions

January 13-14, 2011   Download Final Agenda     Register by this Friday and Save!

Part of CHI's 10th Annual PepTalk 2011 - The Protein Science Week | January 10-14, 2011 | Hotel Del Coronado | San Diego, CA | www.chi-peptalk.com

Computational life science modeling has emerged as an important tool from academic research to advance industrial applications which support strategic decision making throughout the protein production pipeline. High-throughput technologies are producing reliable and quantitative data that aid engineering methods to model complex biological systems. This meeting provides the opportunity for protein scientists, engineers, and chemists generating data, computer engineers and bioinformaticists modeling data, and drug developers, formulators, and bioprocessors utilizing the data models to foster discussion and drive production strategies in this dynamic research discipline.  
ENA Content Coordinator position PDF Print E-mail
Written by Virginia Gonzalez   
Saturday, 06 November 2010 23:11
The following is a great vacancy in biocuration and the management of a team of biocurators at the European Bioinformatics Institute in Cambridge, UK. The European Nucleotide Archive project features both the well established annotated sequence repository and the cutting edge archive for next generation sequencing data, SRA. The position offers substantial opportunities to shape the way biocuration develops for this critical and foundational data resource for the life sciences.

Please direct informal enquiries to Guy Cochrane ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ), but note that all applications must be received through EBI's formal application procedure, available from http://tinyurl.com/29kzzld.
Written by Virginia Gonzalez   
Thursday, 04 November 2010 15:03
May 27-29, 2011
Central South University, Changsha, China

The International Symposium on Bioinformatics Research and Applications (ISBRA) provides a forum for the exchange of ideas and results among researchers, developers, and practitioners working on all aspects of bioinformatics and computational biology and their applications.  Submissions presenting original research are solicited in all areas of bioinformatics and computational biology, including the development of experimental or commercial systems. Topics of interest include but are not limited to:

 * Biomedical databases and data integration
 * Biomolecular imaging
 * Bio-ontologies
 * Comparative genomics
 * Computational genetic epidemiology
EURASIP Journal on Bioinformatics and Systems Biology PDF Print E-mail
Written by Virginia Gonzalez   
Friday, 05 November 2010 13:16
EURASIP Journal on Bioinformatics and Systems Biology invite you to submit an article to "EURASIP Journal on Bioinformatics and Systems Biology," which provides a rapid forum for the dissemination of original research articles as well as review articles related to the use of signal processing techniques in bioinformatics.

EURASIP Journal on Bioinformatics and Systems Biology is published using an open access publication model, meaning that all interested readers are able to freely access the journal online at http://www.hindawi.com/journals/bsb/contents.html without the need for a subscription. Moreover, articles published in the journal are made available on PubMed Central at the time of publication.

The journal has a distinguished editorial board with extensive academic qualifications, ensuring that the journal maintains high scientific standards and has a broad international coverage. A current list of the journal's editors can be found at http://www.hindawi.com/journals/bsb/editors.html.

Manuscripts should be submitted to the journal online at http://www.hindawi.com/journals/bsb/. Once a manuscript has been accepted for publication, it will undergo language copyediting, typesetting, and reference validation in order to provide the highest publication quality possible.
Clinical Trial Magnifier - Free Electronic Journal PDF Print E-mail
Written by Virginia Gonzalez   
Wednesday, 03 November 2010 14:57
Clinical Investigator Incentives for Participation in Industry-Sponsored Clinical Trials

The Clinical Trial Magnifier 2010 Conference

Date: November 24-26, 2010; Pre-conference courses, 22-24 November, 2010

Location: Kota Kinabalu, Sabah, Malaysia – The Land Below The Wind

Information and Registration: http://www.ctmconference.com

Clinical Trial Magnifier - Free Subscription

During the past decade, conducting industry-sponsored clinical trials has developed into a global phenomenon, where 25% of the study sites are presently located to emerging regions. Since early 2008, this globalization process has been actively covered by the Clinical Trial Magnifier - www.ClinicalTrialMagnifier.com - a free electronic journal, today with 22,660 subscribers representing 157 countries.

The August Magnifier issue covers Clinical Trials Overseen by US FDA: The Office of Inspector General, US Department of Health and Human Services has recently reported that over half of clinical trial subjects and sites were located outside the United States (based on 2008 US FDA approved drugs).  Our analyses of the US trial registry shows slightly different results with relatively more sites for emerging trial regions; East Europe - 6.4% for the Report and 11.0% for the registry data. The figure for Asia goes in the same direction, i.e. 3.4% versus 7.6%.  In addition, about 50% of industry-sponsored trials registered in the US trial registry and conducted in Europe were not overseen by the US FDA. The industry has decided to go global due to the lack of investigators and study participants in North America and Europe. This trend will most certainly continue and a large portion of the trials are not overseen by the US FDA (www.ClinicalTrialMagnifier.com).

Page 11 of 34


Who's Online

We have 38 guests online